Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Migraine

Avert headaches in advance

    • Congress Reports
    • Education
    • Neurology
    • RX
    • Studies
  • 2 minute read

Migraine is one of the most common of the more than 240 forms of headache and significantly restricts sufferers in their daily lives and quality of life. Although the number of patients is extremely high, the disease is often still underestimated and is undertreated. There are now effective ways of averting migraines before they start.

More than 136 million people worldwide are affected by migraine [1]. Both peripheral and central sensitization processes are involved in the underlying complex pathophysiology. A key role is played by calcitonin gene-related peptide (CGRP), the level of which rises in saliva during an attack and can also be detected elevated in the blood in chronic migraine. In a chronic form of the disease, the sufferer suffers from at least 15 headache days per month for more than three months, eight or more of which manifest as migraines. Until recently, oral medications such as antidepressants, antiepileptics, or beta-blockers were the main drugs available to control the disease at an early stage. However, more than 80% of chronic migraine sufferers discontinue oral prophylaxis within a year due to lack of efficacy or intolerable side effects [2,3].

 

 

Insights into pathophysiology

The aim of effective migraine prophylaxis is to reduce the number, severity and duration of migraine attacks (Table 1) . Indications include particular distress, reduced quality of life, and the risk of medication overuse. CGRP antibodies (fremanezumab, galcanezumab, eptinezumab) that specifically dock to the ligand of CGRP have been developed specifically for prevention. This prevents binding of CGRP isoforms to the receptor. Erenumab, on the other hand, binds to the CGRP receptor so that the neurotransmitter can no longer dock. This is because CGRP has been shown to play an important role in the pathophysiology of migraine. CGRP levels increase markedly during an attack and remain elevated in between, especially in the chronic form [4,5].

All study data to date demonstrate a very good benefit-risk profile for the currently available preparations. Side effects may include mainly pain or reaction at the injection site and nasopharyngitis. However, the effect is so convincing that dropout rates are very low. Good results can be achieved even in pretreated patients. The reduction in migraine days per month ranges from 4.3 to 6.6 days for chronic migraine. The responder rate after 3 months ranges from 27% to 57%. Efficacy has also been shown for patients with headaches caused by overuse of painkillers or migraine medications. In addition, effective efficacy with good tolerability has now also been demonstrated for a number of subgroups (e.g., depression, cardiovascular events).

 

Literature:

  1. Stovner LJ, Nichols E, Steiner TJ, et al: Lancet Neurol 2018; 17: 954-976.
  2. Hepp Z, Dodick DW, Varon SF, et al: Cephalalgia 2017; 37: 470-485.
  3. Blumenfeld AM, Bloudek LM, Becker WJ, et al: Headache 2013; 53: 644-655.
  4. Edvinsson L, Haanes KA, Warfvinge K, Krause DN: Nat Rev Neurol 2018; 14: 336-350.
  5. Cernuda-Morollon E, Larossa D, Ramon C, et al: Neurology 2013; 81:1191-1196.
  6. www.dgn.org/leitlinien/3859-ll-030-057-cgrp-addendum-migraene-leitlinie-2019 (last accessed on 25.05.2020)

 

InFo NEUROLOGY & PSYCHIATRY 2020; 18(4): 38 (published 6/30/20, ahead of print).

Autoren
  • Leoni Burggraf
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • migraine
  • Migraine prophylaxis
  • Migraine therapy
Previous Article
  • Spinal muscular atrophy

SMA in adults: the road to personalized treatment

  • Congress Reports
  • Education
  • Neurology
  • RX
View Post
Next Article
  • Heart failure

Empagliflozin Reduces Risk of Cardiovascular Death and Hospitalization Rate in Heart Failure

  • Cardiology
  • Congress Reports
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 5 min
  • Vaccine-preventable respiratory diseases

RSV and pneumococci: recommendations for risk groups

    • Congress Reports
    • General Internal Medicine
    • Infectiology
    • Pediatrics
    • Pneumology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 5 min
  • Circadian rhythm in asthma

Chronotherapy can improve control

    • Allergology and clinical immunology
    • General Internal Medicine
    • Pneumology
    • RX
    • Studies
View Post
  • 6 min
  • Update on diagnostics, risk stratification and therapy

Acute myeloid leukemia 2025

    • Education
    • Hematology
    • Oncology
    • RX
    • Studies
View Post
  • 4 min
  • New practice guideline for fibromyalgia syndrome

Good times, bad times

    • Congress Reports
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Physical medicine and rehabilitation
    • Rheumatology
    • RX
    • Sports Medicine
    • Studies
View Post
  • 5 min
  • Findings from the TRACK-FA study

Neuroimaging biomarkers in Friedreich’s ataxia

    • Genetics
    • Neurology
    • Pediatrics
    • RX
    • Studies
View Post
  • 12 min
  • Doing sport without fear or risk

Doing sport without fear or risk

    • CME continuing education
    • Endocrinology and Diabetology
    • Pediatrics
    • RX
    • Sports Medicine
View Post
  • 8 min
  • Chronic inducible urticaria

What has stayed the same, what has changed?

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 4 min
  • National Health Report 2025

Mental health in Switzerland

    • General Internal Medicine
    • Practice Management
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Doing sport without fear or risk
  • 2
    UV protection and skin cancer screening – Update 2025
  • 3
    Rare malignancy from a dermatological perspective
  • 4
    Yellow nail and Swyer-James syndrome
  • 5
    Diagnostic indications

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.